SAO · DASA3.SA
Diagnósticos da América S.A.
R$3.01+R$0.06 (+2.03%)
Diagnósticos da América S.A.’s quoted price sits in the lower half of its reported 52-week range, 48.01% below the high.
Loading market information…
SAO · ONCO3.SA · BRL
Stock price, earnings
Quote as of Oct 30, 2026, 07:54 PM UTC. Cached market data; not a live quote.
One-year closing-price history · BRL. Historical prices are not a forecast.
Oncoclínicas do Brasil Serviços Médicos S.A.’s quoted price sits in the lower half of its reported 52-week range, 74.92% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Oncoclínicas do Brasil Serviços Médicos S.A.’s next earnings report is currently expected on Nov 11, 2026, with estimated earnings per share of -R$0.03. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Oncoclínicas do Brasil Serviços Médicos S.A.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Oncoclínicas do Brasil Serviços Médicos S.A., together with its subsidiaries, provides oncology, hematology, radiotherapy, and genomics healthcare services in Latin America. The company offers treatment services, including radiotherapy, hormone therapy, immunotherapy, port-a-cath, palliative care, target therapy, breast cancer hormone therapy, bone marrow transplant, non-oncological infusions, chemotherapy, oral chemotherapy, and prostate cancer hormone therapy; and surgery procedures, such as breast, head and neck, lung, prostate cancer, stomach, bladder cancer, oncological, kidney cancer, gynecological, and testicular cancer. It also provides diagnostics services comprising pathological analysis, genetic testing, molecular journey, personalized medicine and individualized treatment, myelogram-bone marrow biopsy, and ONCO test-PDO. In addition, the company offers treatment support services, which include veinviewer, cryotherapy, integrative medicine, and DeLife, as well as hilotherapy, laser therapy, OC care line, OC precision medicine, OncoACCESS, survivorship, and telemedicine services. Oncoclínicas do Brasil Serviços Médicos S.A. was founded in 2010 and is headquartered in São Paulo, Brazil.
Latest available per-share figures in BRL. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:17 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| R$1.46B-7.03% vs estimate |
| Q1 2025 | May 15, 2025 | -R$0.21-957.22% vs estimate | R$1.49B-7.74% vs estimate |
|---|
| Q4 2024 | Mar 28, 2025 | -R$1.02-2,708.73% vs estimate | R$1.57B-2.62% vs estimate |
|---|
| Q3 2024 | Nov 13, 2024 | R$0.01-90.0% vs estimate | R$1.63B+0.28% vs estimate |
|---|
KEEP COMPARING
R$3.01+R$0.06 (+2.03%)
Diagnósticos da América S.A.’s quoted price sits in the lower half of its reported 52-week range, 48.01% below the high.
R$9.14-R$0.21 (-2.25%)
Blau Farmacêutica S.A.’s quoted price sits in the lower half of its reported 52-week range, 36.97% below the high.
R$2.51-R$0.05 (-1.95%)
Empreendimentos Pague Menos S.A.’s quoted price sits in the lower half of its reported 52-week range, 67.06% below the high.
R$10.12-R$0.17 (-1.65%)
Dimed S.A. Distribuidora de Medicamentos’s quoted price sits in the lower half of its reported 52-week range, 38.93% below the high.
R$6.69+R$0.09 (+1.36%)
Profarma Distribuidora de Produtos Farmacêuticos S.A.’s quoted price sits in the lower half of its reported 52-week range, 31.03% below the high.
R$5.38+R$0.03 (+0.56%)
Biomm S.A.’s quoted price sits in the lower half of its reported 52-week range, 44.82% below the high.
R$2.47+R$0.01 (+0.41%)
Allianca Saude e Participacoes S.A.’s quoted price sits in the lower half of its reported 52-week range, 60.1% below the high.
R$1.32+R$0.02 (+1.54%)
Qualicorp Consultoria e Corretora de Seguros S.A.’s quoted price sits in the lower half of its reported 52-week range, 51.65% below the high.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
